EUVIMEDAtrasti EUVIMED
Klinische StudieKlinische Studie (Phase III)Randomisierte kontrollierte Studie

Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study

P Dufour, J M Lang, C Giron, B Duclos, P Haehnel, D Jaeck, J M Jung, F Oberling

Biotherapy · 1993-01 · 6 (1) · 9-12

DOI: 10.1007/bf01877380 ↗

At a glance

Klinische Studie in Biotherapy, 1993-01. Written by P Dufour and 7 co-authors. Institution: Service Onco-Hématologie, CHU de Hautepierre, Strasbourg, France. Cited 76 times so far (Crossref); 19 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Sixty-four patients with non metastatic high risk breast cancer were randomized in a double blind trial of adjuvant immunotherapy with sodium dithiocarb (DDC) versus placebo. All patients underwent prior surgery (mammectomy according to Patey) then adjuvant FAC chemotherapy +/- DDC. With a median follow-up of 5 years we observed 6 relapses and 5 deaths in DDC group; 13 relapses and 12 deaths in control group. At 6 years, overall survival is 81% in DDC group versus 55%. Disease free survival (DFS) is 76% in DDC group versus 55%. DDC associated to chemotherapy and locoregional treatment can improve survival and probably DFS in this high risk breast cancer subgroup.

Subjects

MeSH terms (MEDLINE)

Adjuvants, ImmunologicAdultAgedBreast NeoplasmsCombined Modality TherapyDitiocarbDouble-Blind MethodFemaleFollow-Up StudiesHumansMiddle AgedNeoplasm Recurrence, LocalRisk Factors

Substances

Adjuvants, ImmunologicDitiocarb

Authors and institutions

  • Service Onco-Hématologie, CHU de Hautepierre, Strasbourg, France.

Cite

APA

Dufour, P., Lang, J. M., Giron, C., Duclos, B., Haehnel, P., Jaeck, D., Jung, J. M., & Oberling, F. (1993). Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy, 6(1), 9-12. https://doi.org/10.1007/bf01877380

Vancouver

Dufour P, Lang JM, Giron C, Duclos B, Haehnel P, Jaeck D, et al. Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy. 1993;6(1):9-12. doi:10.1007/bf01877380

BibTeX
@article{Dufour1993,
  author = {Dufour, P and Lang, J M and Giron, C and Duclos, B and Haehnel, P and Jaeck, D and Jung, J M and Oberling, F},
  title = {Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study},
  journal = {Biotherapy},
  year = {1993},
  volume = {6},
  number = {1},
  pages = {9--12},
  doi = {10.1007/bf01877380}
}
Start for free →